Aspirin DL-Lysine is the lysine salt form of acetylsalicylic acid, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic and anti-inflammatory activities. Like other NSAIDs, aspirin DL-lysine inhibits the activity of cyclooxygenase I and II, resulting in decreased formation of prostaglandins (PGs) and thromboxanes precursors. This leads to decreased PG synthesis by PG synthase. This agent also causes a decrease in the formation of thromboxane A2 synthesis by thromboxane synthase, thereby inhibiting platelet aggregation. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Aspidol, Aspirisine, Egicalm and Vetalgine. Its PubChem CID is 9905405.
Aspisol
| CAS No | 62952-06-1 |
|---|---|
| Molecular Formula | C15H22N2O6 |
| Molecular Weight | 326.34 g/mol |
| Synonyms | 2-acetyloxybenzoic acid;2,6-diaminohexanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Aspirin DL-Lysine is the lysine salt form of acetylsalicylic acid, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic and anti-inflammatory activities.
The listed CAS number is 62952-06-1.
The listed molecular formula is C15H22N2O6.
The listed molecular weight is 326.34 g/mol.
2-acetyloxybenzoic acid;2,6-diaminohexanoic acid.
The source lists Aspidol, Aspirisine, Egicalm and Vetalgine.